𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

✍ Scribed by Naoyo Nishida; Hirohisa Yano; Kan Komai; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
424 KB
Volume
101
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

The vascular endothelial growth factor (VEGF) family and VEGF receptors (VEGFR) play an essential role in the angiogenesis of both pathologic and nonpathologic conditions. However, the prognostic significance of VEGF and VEGFR expression in ovarian carcinoma is unclear.

METHODS

The tissue expression levels of VEGF‐A, VEGF‐C, VEGFR‐2, and VEGFR‐3 in 80 specimens of ovarian carcinoma were examined immnohistochemically. The results obtained were analyzed clinicopathologically.

RESULTS

VEGF‐A, VEGF‐C, VEGFR‐2, and VEGFR‐3 were expressed both in tumor cells and in adjacent endothelial cells of blood and lymph vessels. The tissue expressions of VEGF‐C and VEGFR‐2 were correlated significantly with tumor extension, including peritoneal metastases outside the pelvic cavity (P = 0.0010 and P = 0.0008, respectively), lymph node metastases (P = 0.0030 and P = 0.0018, respectively), and positive ascitic cytology (P = 0.025 and P = 0.0016, respectively). Conversely, there was no significant correlation between VEGF‐A and VEGFR‐3 expression and clinicopathologic features of ovarian carcinoma. Logistic regression analysis revealed that the expressions of VEGF‐C and VEGFR‐2 also were independent risk factors for peritoneal and lymph node metastases. Survival curves determined by the Kaplan–Meier method and in univariate analysis demonstrated that high expression levels of VEGF‐C and VEGFR‐2 were associated with the 5‐year survival rate. In multivariate analysis, high expression levels of VEGF‐C and VEGFR‐2 emerged as independent indicators for disease‐specific survival.

CONCLUSIONS

High tissue expression of VEGF‐C and VEGFR‐2 reflects the aggressiveness of the spread of tumor in ovarian carcinoma. Thus, both have predictive value for identifying high‐risk patients who have a poor prognosis. Cancer 2004. © 2004 American Cancer Society.


📜 SIMILAR VOLUMES


Clinical significance of vascular endoth
✍ Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGF‐C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR‐3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the

Vascular endothelial growth factor and s
✍ Susan K. Lutgendorf; Erica L. Johnsen; Brian Cooper; Barrie Anderson; Joel I. So 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: The modulation of immunologic activities relevant to cancer by behavioral factors, such as stress, depression, and social support, is well documented. however, associations of behavioral factors with cytokines involved in tumor angiogenesis have not been studied. vascular endothelial

Vascular endothelial growth factor C and
✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph

Vascular endothelial growth factor and v
✍ Antonio Rueda; Oscar Cazorla; Lidia Pérez; Martina Álvarez; Maximino Redondo; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 813 KB

## Abstract ## Background Vascular endothelial growth factor (VEGF) expression seems to be associated with worse overall survival in patients with head and neck squamous cell carcinoma. The purposes of this study were to assess the prognostic values of the immunohistochemical expression of VEGF an